ITOS — iTeos Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for iTeos Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	336	849	613	532	495
Net Total Receivables	0.325	12.1	2.44	6.5	3.69
Prepaid Expenses
Total Current Assets	340	875	628	551	510
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.35	7.4	6.77	10.7	9.98
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	345	885	755	668	687
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	15	304	42	40	40.4
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	21.4	332	91.7	92.4	96.7
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	323	553	663	575	590
Total Liabilities & Shareholders' Equity	345	885	755	668	687
Total Common Shares Outstanding